Korean Market
EXCH
Samsung Biologics
★

Samsung Life Insurance Special Account Sells 3,001 Shares of Samsung Biologics via Open Market; Stake Edges Down to 74.30%, Minimal Impact on Shareholder Value

 
EXCH
Samsung Biologics
★

Samsung Biologics Publishes 2026 ESG Report: Transparent Disclosure of Sustainability Performance

 
EXCH
Samsung Biologics
★

Samsung Biologics Corporate Governance Report Disclosed: Excellent Transparency but Neutral Impact Due to Lack of Shareholder Return Policy

 
FTC
Samsung Biologics
★

Samsung Biologics Invests 79.2B KRW in Life Sciences Venture Fund for Future Growth

 
FTC
Samsung Biologics
★

Samsung Biologics Annual Conglomerate Disclosure – Sound Financials, Stable Ownership at 74.39% by Affiliates, No Material Events

 
OWNR
Samsung Biologics
★

Samsung Biologics Exec Jo Seong-hwan Withdraws 50 Shares from ESOP

 
PERI
Samsung Biologics
★★★

Samsung Biologics: Strong Q1 2026 Results and US Production Base Acquisition

 
PERI
Samsung Biologics
★★

Samsung Biologics: 2025 Consolidated Revenue +30%, Operating Profit +57%... Spin-off Focuses on CDMO

 
EXCH
Samsung Biologics
★

Samsung Life Insurance Special Account Slightly Sells Samsung Biologics Shares; No Change in Major Shareholder Stake